C. Gandolfi

605 total citations
45 papers, 467 citations indexed

About

C. Gandolfi is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, C. Gandolfi has authored 45 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in C. Gandolfi's work include Inflammatory mediators and NSAID effects (7 papers), Steroid Chemistry and Biochemistry (6 papers) and Chemical Synthesis and Analysis (4 papers). C. Gandolfi is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Steroid Chemistry and Biochemistry (6 papers) and Chemical Synthesis and Analysis (4 papers). C. Gandolfi collaborates with scholars based in Italy, United States and Chile. C. Gandolfi's co-authors include R. Malvano, P. Grosso, R. Ceserani, S. Bianco, M. Robuschi, Daniela Giannessi, G. P. POLLINI, A. BARCO, Simonetta Benetti and Pier Giovanni Baraldi and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Bone and Mineral Research and The Journal of Organic Chemistry.

In The Last Decade

C. Gandolfi

44 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Gandolfi Italy 13 151 138 90 66 57 45 467
John Bruno United States 17 274 1.8× 253 1.8× 94 1.0× 58 0.9× 82 1.4× 27 658
Furn F. Knapp United States 16 245 1.6× 314 2.3× 56 0.6× 31 0.5× 140 2.5× 41 871
N. YONEDA Japan 16 352 2.3× 254 1.8× 47 0.5× 40 0.6× 54 0.9× 75 744
Steven A. Boyd United States 18 320 2.1× 322 2.3× 63 0.7× 99 1.5× 71 1.2× 34 739
Kiyoshi Oizumi Japan 16 141 0.9× 228 1.7× 36 0.4× 68 1.0× 183 3.2× 28 588
Hiroshi Akutsu Japan 12 160 1.1× 129 0.9× 24 0.3× 69 1.0× 141 2.5× 39 511
Miyako Kato Japan 10 195 1.3× 91 0.7× 218 2.4× 39 0.6× 22 0.4× 13 621
Arthur Mazzu United States 11 158 1.0× 117 0.8× 42 0.5× 19 0.3× 71 1.2× 24 570
Paavo Pasanen Finland 14 229 1.5× 87 0.6× 24 0.3× 34 0.5× 30 0.5× 27 684
H. Narjes Germany 11 75 0.5× 111 0.8× 158 1.8× 26 0.4× 69 1.2× 17 461

Countries citing papers authored by C. Gandolfi

Since Specialization
Citations

This map shows the geographic impact of C. Gandolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gandolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gandolfi more than expected).

Fields of papers citing papers by C. Gandolfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Gandolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gandolfi. The network helps show where C. Gandolfi may publish in the future.

Co-authorship network of co-authors of C. Gandolfi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Gandolfi. A scholar is included among the top collaborators of C. Gandolfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Gandolfi. C. Gandolfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gandolfi, C., et al.. (1998). [A new steroid having proteo-anabolic action: dimethazine].. PubMed. 47. 1–19. 1 indexed citations
2.
Gandolfi, C., Gino Beggiolin, Ernesto Menta, et al.. (1995). Chromophore-Modified Antitumor Anthracenediones: Synthesis, DNA Binding, and Cytotoxic Activity of 1,4-Bis[(aminoalkyl)amino]benzo[g]phthalazine-5,10-diones. Journal of Medicinal Chemistry. 38(3). 526–536. 25 indexed citations
3.
Gandolfi, C., Roberto Di Domenico, Silvano Spinelli, et al.. (1995). N-Acyl-2-substituted-1,3-thiazolidines, a new class of non-narcotic antitussive agents: studies leading to the discovery of ethyl 2-[(2-methoxyphenoxy)methyl]-.beta.-oxothiazolidine-3-propanoate. Journal of Medicinal Chemistry. 38(3). 508–525. 16 indexed citations
4.
Vío, Carlos P., et al.. (1990). Effect of cyclosporine A on the distal nephron: the use of kallikrein as a specific morphological marker.. PubMed. 22(4). 1730–2. 5 indexed citations
5.
Mongelli, Nicola, et al.. (1988). 1-Fluorocycloalkanecarboxylic Acids in the Synthesis of 16-Achiral 16-Fluoro-9a-carbaprostacyclin Derivatives. Synthesis. 1988(4). 310–313. 9 indexed citations
6.
Morley, John E., Clive Page, William Paul, et al.. (1983). A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo. Prostaglandins Leukotrienes and Medicine. 11(4). 391–399. 13 indexed citations
7.
Mongelli, Nicola, et al.. (1983). Perhydropentalenone equivalent from corey's lactone. Tetrahedron Letters. 24(33). 3527–3530. 2 indexed citations
8.
Longo, Antonio, Paolo Lombardi, C. Gandolfi, & Giovanni Franceschi. (1981). 4-tetrahydropyranthioazetidinyl phosphoranes: Versatile intermediates in the synthesis of 2-penems. Tetrahedron Letters. 22(4). 355–358. 7 indexed citations
9.
BARCO, A., Simonetta Benetti, G. P. POLLINI, et al.. (1981). Elaboration of the .omega.-chain of 11-deoxyprostanoid derivatives through isoxazole intermediates. The Journal of Organic Chemistry. 46(22). 4518–4524. 10 indexed citations
10.
Bianco, S., et al.. (1979). Effect of prostacyclin on antigfn inducfd ifowdiatf rronchoconstriction in astmatic patients. Prostaglandins and Medicine. 3(1). 39–45. 14 indexed citations
11.
Malvano, R., et al.. (1976). Radioimmunoassay of aldosterone in crude plasma extracts.. PubMed. 20(1). 37–44. 50 indexed citations
12.
Ceserani, R., et al.. (1975). Prostagiandins IX: 8,12-diiso-PGE2: Effect of steric configuration of side chains on biological activity. Prostaglandins. 9(1). 97–107. 6 indexed citations
13.
Ceserani, R., et al.. (1974). Prost aglandins VII: 8–12 diisoprostaglandins: Synthesis and biological activities. Pharmacological Research Communications. 6(5). 437–444. 4 indexed citations
14.
Malvano, R., et al.. (1974). Insulin radioimmunoassay: a comparison of three methods.. PubMed. 18(2). 80–6. 5 indexed citations
15.
Gandolfi, C., et al.. (1972). Prostaglandins : by-products in BBr3-cleavage on corey's methylether intermediate. Tetrahedron Letters. 13(20). 2063–2065. 4 indexed citations
16.
Gandolfi, C., R. Malvano, & U. Rosa. (1971). Preparation and immunoreactive properties of monoiodinated angiotensin labelled at high specific activity. Biochimica et Biophysica Acta (BBA) - Protein Structure. 251(2). 254–261. 10 indexed citations
17.
Gandolfi, C., et al.. (1970). Conjugate addition of reformatsky reagents to Δ 16-20-ketosteroids. Tetrahedron Letters. 11(45). 3923–3926. 4 indexed citations
18.
Ruggieri, Pietro, C. Gandolfi, & Umberto Guzzi. (1967). Steroids XXVIII. 10β-amino-steroids: a new class of steroid derivatives. Tetrahedron Letters. 8(23). 2195–2200. 2 indexed citations
19.
Ruggieri, Pietro, C. Gandolfi, & Umberto Guzzi. (1966). aromatization reactions of some 19-nor-androstane derivatives. Tetrahedron Letters. 7(2). 205–210. 3 indexed citations
20.
Gandolfi, C., et al.. (1962). [A new series of steroids with protein anabolic action].. PubMed. 38. 985–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026